Oral sex may be contributing to the increasing number of throat cancer cases, according to health experts. UK radio presenter Jamie Theakston, 53, recently revealed his stage one laryngeal cancer diagnosis after listeners noted a change in his voice. He announced he will be taking a break from his role at Heart Radio.
Dr. Hisham Mehanna from the University of Birmingham highlighted that around 70 percent of throat cancer cases are linked to human papillomavirus (HPV). He noted that having multiple oral sex partners can increase the risk of developing throat cancer by up to nine times.
While smoking and alcohol consumption have long been associated with head and neck cancers, new research indicates that HPV is becoming a significant contributor. Dr. Mehanna stated that there has been a rapid rise in throat cancer cases in Western countries, prompting some experts to label it an “epidemic.” In the UK alone, approximately 12,800 new cases are diagnosed each year, with around 71,100 cases in the US.
HPV is a virus commonly spread through sexual contact, and it is estimated that around 80 percent of people will carry it at some point in their lives. While it typically causes no issues, certain strains—particularly HPV 16 and 18—can lead to cancer by triggering cell changes in the body.
Laryngeal cancer, which affects the voice box, is four times more common in men and is often diagnosed in individuals in their 60s. Common symptoms include persistent hoarseness, pain when swallowing, and lumps in the neck. Early detection is crucial, as survival rates can be as high as 65 percent five years after diagnosis.
Theakston’s co-star Amanda Holden provided an update on his health, reassuring fans of his positive outlook following the early-stage diagnosis. Professor Peter Johnson, NHS England’s national clinical director for cancer, emphasized the importance of early detection and awareness of cancer symptoms, encouraging people to seek medical advice when they notice concerning signs.
HPV vaccines, offered to 12- and 13-year-olds in the UK and US, have shown effectiveness in reducing rates of head and neck cancers. Despite progress, healthcare professionals urge greater public awareness regarding the link between oral sex and HPV-related cancers.
Research indicates that a significant majority of both men (85.4 percent) and women (83.2 percent) engage in oral sex, highlighting the need for education about the associated risks. HPV is linked to several cancers, including those of the mouth, throat, cervix, anus, and penis.
In related news, actor Michael Douglas revealed in 2013 that his mouth cancer diagnosis was likely linked to oral sex. He successfully underwent treatment and remains cancer-free.
Vaccination against HPV is critical; it is over 80 percent effective and available in many developed countries. A two-dose vaccine is recommended for children ages 11 to 12, while a three-dose option is available for individuals aged 15 to 26 who missed the initial window. The vaccine has been offered to girls in England and Wales since 2008 and was extended to boys in 2019. It not only helps prevent cervical cancer but has also proven effective in reducing head and neck cancer rates.
What is Laryngeal Cancer?
Laryngeal cancer affects the larynx (voice box), a vital structure located at the entrance of the windpipe. In the UK, about 2,300 cases are diagnosed each year, with men being four times more likely to be affected, particularly those in their 60s. The primary symptom is a hoarse voice lasting more than three weeks, with additional symptoms including changes in voice, pain or difficulty swallowing, and a lump in the neck.
Diagnosis and treatment vary depending on the cancer’s stage, with early-stage laryngeal cancer typically treated through radiation and surgery. Advanced cases may necessitate the removal of the entire larynx and chemotherapy, significantly impacting speech and breathing. Early detection improves survival rates, with about 65 percent of patients surviving five years post-diagnosis. Laryngeal cancer is part of a broader category of head and neck cancers, which claim over 4,000 lives in the UK annually.
